A framework for addressing Alzheimer’s disease: Without a frame, the work has no aim
This is my archive
Improving community health-care systems’ early detection of cognitive decline and dementia
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force
Projected Ontario budget savings from reduced long-term care utilization due to a disease-modifying Alzheimer’s treatment
Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer’s disease treatment
Designing the next-generation clinical carepathway for Alzheimer’s disease
From Trials to Practice: Are We Ready for a Disease-Modifying Treatment?
Projecting the long-term societal value of a disease-modifying treatment for Alzheimer’s disease in the United States
Why would Canada have the longest wait times for an Alzheimer’s treatment among the G7 countries?
Association of Adverse Events in Opioid Addiction Treatment With Quality Measure for Continuity of Pharmacotherapy
